AZ 628
Cat. No.：YN350065
CAS No. ：878739-06-1
| 产品名称: | AZ 628 |
| CAS No.: | 878739-06-1 |
| Chemical Name: | 3-(1-cyano-1-methylethyl)-N-[3-[(3,4-dihydro-3-methyl-4-oxo-6-quinazolinyl)amino]-4-methylphenyl]-benzamide |
| Synonyms: | AZ-628,cas 878739-06-1,AZ 628,AZ628 |
| 分子量: | 451.52 |
| 分子式: | C₂₇H₂₅N₅O₂ |
| SMILES: | O=C1N(C)C=NC2=C1C=C(C=C2)NC3=C(C)C=CC(NC(C4=CC(C(C#N)(C)C)=CC=C4)=O)=C3 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | AZ 628 是一种泛Raf激酶抑制剂，抑制B-Raf，B-RafV600E，和c-Raf-1，IC50分别为 105，34，和 29 nM。 |
| IC50和靶点: | [{name:"c-Raf-1:29 nM (IC50)"},{name: "B-RafV600E:34 nM (IC50)"},{name: "B-Raf:105 nM (IC50)"}] |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Lyons, J.F., Wilhelm, S., Hibner, B., et al.Discovery of a novel Raf kinase inhibitorEndocr. Relat. Cancer8(3),219-225(2001)
Wang, X., and Kim, J.Conformation-specific effects of Raf kinase inhibitorsJ. Med. Chem.55(17),7332-7341(2012)
Flaherty, K.T., Puzanov, I., Kim, K.B., et al.Inhibition of mutated, activated BRAF in metastatic melanomaN. Engl. J. Med.363(9),809-819(2010)
Old, W.M., Shabb, J.B., Houel, S., et al.Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanomaMol. Cell34(1),115-131(2009)
Nucera, C., Porrello, A., Antonello, Z.A., et al.B-RafV600E and thrombospondin-1 promote thyroid cancer progressionProc. Natl. Acad. Sci. USA107(23),10649-10654(2010)
Tsai, J., Lee, J.T., Wang, W., et al.Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityProc. Natl. Acad. Sci. USA105(8),3041-3046(2008)
Khazak, V., Astsaturov, I., Serebriiskii, I.G., et al.Selective Raf inhibition in cancer therapyExpert Opin. Ther. Targets11(12),1587-1609(2007)
Montagut, C., Sharma, S.V., Shioda, T., et al.Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanomaCancer Res.68(12),4853-4861(2008)
